Other planned ONCAs

BCCT plans summaries of off-label, overlooked or novel cancer approaches (ONCAs) to include these:

  • Amino-bisphosphonates
  • Chloroquine
  • Chloroquine
  • Cimetadine
  • Clarithromycin
  • Gossypol
  • Interleukin 2 with taurolidine
  • Low-dose cyclophosphamide
  • Low-dose immune checkpoint inhibitors
  • Metronomic dose chemotherapy
  • Mifepristone
  • Noscapine
  • NSAIDs, including COX 2 inhibitors and aspirin
  • Persantine
  • Rapamycin

Enter your comments or questions below.

Comments (0)




Allowed tags: <b><i><br>Add a new comment: